DApp Store

All chains arrowright

All chains

Manta

zkSync Era

Base

Linea

Chiliz

ETH

BSC

Polygon

Sei

Sei V2

Plume

Fuel

World Chain

Sonic

Katana

Hyper EVM

Monad Testnet

Monad

Sahara AI Testnet

Plasma Testnet

Lens

Babylon Genesis

Hemi Network

svmBNB

Abstract Mainnet

Soneium

Berachain

Story Mainnet

Matchain

Arbitrum

Optimism

Bitcoin

Bitcoin Testnet

Bitcoin Signet

ZetaChain Mainnet

Zeta Evm Testnet

opBNB

Scroll

Core

Mantle

Sui

TRON

Solana

Aptos

Movement Testnet

SOON Devnet

SOON Mainnet

Fantom

Starknet old

Starknetv2

Nautilus

Polygon zkEVM

Avalanche-C

Celo

Heco

OKC Chain

KLAY

Cronos

WAX

Gnosis Chain

EOS

Terra Classic

NEAR Protocol

Harmony

Aurora

KCC Chain

Boba Network

Fuse

KardiaChain

IOST

ClassZZ

Caduceus

TRUE

Velas

smartBCH

Vision

Cosmos

TomoChain

Findora

GateChain

BitTorrent

Callisto Mainnet

Meter Mainnet

HALO

Yotta

IoTeX

Kava

BRISE

Telos

DogeChain

zkSync

PEGO

Fsc Scan

ThunderCore

Conflux eSpace

Shardeum Liberty 2.X

Ethereum Classic

Berachain Artio

Artio Testnet (Berachain)

Morph Testnet

Morph Holesky

Morph

Lumia

Merlin Chain

Sonic Testnet

Osmosis

Nillion Testnet

XION

Babylon Testnet

zkfair

Blast

Degen

Bitlayer

Taiko

Celestia

Saga

Mode

Ton

Coreum

BOB

Aleph Zero EVM

MEGA Testnet

Stellar

Kite Testnet

X Layer

Ethereum Sepolia

Noble

Stable Testnet

0G Mainnet

Plasma Mainnet

Ink

JuChain

Morph Hoodi

Pharos Testnet

PopChain

Artelo Biosciences

Artelo Biosciences Inc. (Nasdaq: ARTL) is a clinical-stage biopharmaceutical company focused on developing therapeutics that modulate lipid signaling pathways. The company's pipeline includes drug candidates targeting pain, inflammation, anxiety, and cancer-related conditions. The company is utilizing clinical trials to validate their safety and efficacy, and utilizes an outsourced model for both R&D and manufacturing management.

What is Artelo Biosciences?

Artelo Biosciences, Inc. is a clinical-stage pharmaceutical company dedicated to developing and commercializing proprietary therapeutics that modulate lipid-signaling pathways. Their diversified pipeline addresses significant unmet needs in anorexia, cancer, anxiety, dermatologic conditions, pain, and inflammation.

How Does Artelo Biosciences Work?

Artelo focuses on advancing a portfolio of product candidates designed to modulate lipid-signaling pathways. This approach involves developing therapies that target specific lipid-related mechanisms to treat various diseases and conditions.

What Makes Artelo Biosciences Unique?

Artelo's unique approach lies in its focus on lipid-signaling pathways, which are critical in various physiological processes. Their diversified pipeline targets multiple conditions, including anorexia, cancer, and anxiety, aiming to address significant unmet medical needs.

Who Are the Founders of Artelo Biosciences?

Gregory D. Gorgas serves as the President and Chief Executive Officer of Artelo Biosciences. He has three decades of experience in drug development and commercialization, including leadership roles at Biogen and Mast Therapeutics. Dr. Martin Emanuele, a board member, brings over 30 years of biopharmaceutical industry experience, having held senior executive positions at companies like CytRx Corp. and Avanir Pharmaceuticals.

Latest News

What Key Events Have There Been for Artelo Biosciences?

In May 2025, Artelo Biosciences provided a business update and reported its first-quarter 2025 financial results, highlighting progress in their clinical programs and financial standing.

Project Announcements

Artelo Biosciences announced the advancement of their lead product candidate, ART27.13, into Phase 1b/2a clinical trials for the treatment of anorexia associated with cancer.

Upcoming Events

No data

Projects Announcements

Where to Buy Artelo Biosciences?

Artelo Biosciences' common stock is listed on the NASDAQ stock exchange under the ticker symbol ARTL.

Artelo Biosciences Price

Daily Trading Volume

As of October 31, 2025, the daily trading volume for ARTL is approximately 512,639 shares.

All-Time High

The all-time high for ARTL was $18.9999, reached on October 30, 2025.

All-Time Low

The all-time low for ARTL was $14.6183, recorded on October 30, 2025.

Market Cap and Valuation

Market Cap

As of October 31, 2025, the market capitalization of Artelo Biosciences is approximately $16.59 million.

Fully Diluted Valuation

Specific data on the fully diluted valuation is not available.

Artelo Biosciences Price Prediction

Currently, there are no available forecasts from reliable experts or publications regarding the future price of Artelo Biosciences' stock.

FAQ

What is the Purpose of Artelo Biosciences?

How Can I Participate in Artelo Biosciences' Ecosystem?

What Sets Artelo Biosciences Apart from Competitors?

Is Artelo Biosciences Secure?

What are the Risks Associated with Artelo Biosciences?

Community Sentiment

31.22K Votes

50% 50%

Disclaimer and Risk Warning: Some content on this page may be assisted or generated by AI and is for general reference only. For the most accurate and updated information, please refer to the official website of the project. Bitget Wallet values every partnership. If you notice any issues or inaccuracies, feel free to reach out to us at [email protected] — we appreciate your feedback and will make improvements where needed.